Document text
Principal Investigator: Mark M Painter
Organization: UNIVERSITY OF PENNSYLVANIA
Fiscal Year: 2024
Award: $76,756
Funding agency: National Institute of Allergy and Infectious Diseases
Project Summary/Abstract
CD8 T cells are critical to the adaptive immune response to viral pathogens. When neutralizing antibodies are
insufficient to prevent viral infection outright, virus-specific memory CD8 T cells can rapidly kill infected cells and
limit the severity of infection. This has recently been identified as a potentially key mechanism by which COVID-
19 disease severity is reduced in vaccinated individuals. Memory CD8 T cells are functionally heterogeneous
within and between individuals, with some cells more capable of effectively responding during viral infection. In
the worst cases, dysfunctional CD8 T cell responses or ongoing responses to chronic viral infections could cause
persistent and debilitating symptoms, as may be the case in Long COVID. Our understanding of the dynamics
of human CD8 T cell differentiation remains incomplete, including why individuals generate functionally different
responses to an identical antigen. Developing effective vaccines will require an understanding of shared
molecular programs that can lead to potent effector responses across a range of individual immune landscapes
and CD8 T cell identities. Two key gaps in knowledge impair our ability to fully leverage the potential of T cells
in vaccines. First, little is known about the lineages that produce functionally distinct T cells in humans and what
factors promote different lineages. Second, it is unclear which CD8 T cell states retain the greatest capacity to
mount a potent effector response to combat infection. Therefore, there is an urgent need to define human
memory CD8 T cell differentiation trajectories, how they impact future responses to viral pathogens, and how
they may be dysregulated in cases where symptoms fail to resolve, such as Long COVID. We will address this
need by testing three working hypotheses: first, that T cell clones differentiate down lineages with distinct
functional capacities; second, that epigenetic features leave some lineages poised to mount more potent
responses; and third, that the immune landscape influences CD8 T cell differentiation and functionality, with
multiple classes of immune dysregulation driving Long COVID pathology. In Aims 1-2, we will use custom HLA-
I/peptide tetramers to sort rare Spike-specific CD8 T cells from 5 individuals at each of a longitudinal series of
memory and acute responding time points. We will then perform two cutting-edge single-cell sequencing
approaches that use T cell receptor and mitochondrial variant sequences to define T cell clones and track the
differentiation of these clones over time while assessing cell states by mRNA expression, protein expression,
and chromatin accessibility. Aim 3 will use a systems immunology approach in healthy vaccinees and Long
COVID patients to identify features of the immune landscape that correlate with optimal, sub-optimal, and
dysregulated CD8 T cell responses. Collectively, these studies will evaluate multiple possible causes of Long
COVID and will define the CD8 T cell differentiation lineages that produce optimal responses, providing a
blueprint for improved vaccines to reduce severe disease caused by SARS-CoV-2, Influenza, and other viruses.
Terms: <2019 novel corona virus><2019 novel coronavirus><2019-nCoV><Activities of Daily Living><Activities of everyday life><Acute><Affect><Antibodies><Antigens><Automobile Driving><Autoregulation><Blood Sample><Blood Serum><Blood specimen><CD4 Cells><CD4 Positive T Lymphocytes><CD4 T cells><CD4 helper T cell><CD4 lymphocyte><CD4+ T-Lymphocyte><CD4-Positive Lymphocytes><CD8 Cell><CD8 T cells><CD8 lymphocyte><CD8+ T cell><CD8+ T-Lymphocyte><CD8-Positive Lymphocytes><CD8-Positive T-Lymphocytes><COVID crisis><COVID disease severity><COVID epidemic><COVID infected patient><COVID pandemic><COVID patient><COVID positive patient><COVID severity><COVID-19 affected><COVID-19 consequence><COVID-19 crisis><COVID-19 disease severity><COVID-19 effect><COVID-19 epidemic><COVID-19 era><COVID-19 global health crisis><COVID-19 global pandemic><COVID-19 health crisis><COVID-19 impact><COVID-19 impacted><COVID-19 infected patient><COVID-19 pandemic><COVID-19 patient><COVID-19 period><COVID-19 positive patient><COVID-19 public health crisis><COVID-19 severity><COVID-19 therapeutics><COVID-19 virus><COVID-19 years><COVID19 disease severity><COVID19 patient><COVID19 positive patient><COVID19 severity><COVID19 virus><Cancers><Cell Body><Cell Lineage><Cells><Cellular biology><Chromatin><Chronic><Clone Cells><CoV-2><CoV2><Complementary DNA><Custom><DNA seq><DNA sequencing><DNAseq><Detection><Development><Disease><Disorder><Epigenetic><Epigenetic Change><Epigenetic Mechanism><Epigenetic Process><Future><Goals><Grippe><Homeostasis><Human><Immune><Immune memory><Immunes><Immunity><Immunochemical Immunologic><Immunologic><Immunologic Memory><Immunological><Immunological Memory><Immunologically><Immunologics><Immunology><Impairment><Individual><Infection><Infection prevention><Influenza><Influenza Virus><Knowledge><Light><Long COVID><Long COVID-19><Long coronavirus disease><Long coronavirus disease 2019><MHC Receptor><Major Histocompatibility Complex Receptor><Malignant Neoplasms><Malignant Tumor><Mediator><Membrane Protein Gene><Membrane Proteins><Membrane-Associated Proteins><Memory><Memory B Cell><Memory B-Lymphocyte><Mitochondria><Mitochondrial DNA><Modern Man><Molecular><Morbidity><Morbidity - disease rate><Non-Polyadenylated RNA><Pathology><Peptides><Persons><Photoradiation><Physiological Homeostasis><Prevent infection><Proliferating><RNA><RNA Gene Products><Research><Research Proposals><Ribonucleic Acid><SARS corona virus 2><SARS-CO-V2><SARS-COVID-2><SARS-CoV-2><SARS-CoV-2 disease severity><SARS-CoV-2 epidemic><SARS-CoV-2 global health crisis><SARS-CoV-2 global pandemic><SARS-CoV-2 infected patient><SARS-CoV-2 pandemic><SARS-CoV-2 patient><SARS-CoV-2 positive patient><SARS-CoV-2 severity><SARS-CoV-2 therapeutics><SARS-CoV2><SARS-associated corona virus 2><SARS-associated coronavirus 2><SARS-coronavirus-2><SARS-coronavirus-2 epidemic><SARS-coronavirus-2 pandemic><SARS-coronavirus-2 therapeutics><SARS-related corona virus 2><SARS-related coronavirus 2><SARSCoV2><Sampling><Series><Serum><Severe Acute Respiratory Coronavirus 2><Severe Acute Respiratory Distress Syndrome CoV 2><Severe Acute Respiratory Distress Syndrome Corona Virus 2><Severe Acute Respiratory Distress Syndrome Coronavirus 2><Severe Acute Respiratory Syndrome CoV 2><Severe Acute Respiratory Syndrome CoV 2 epidemic><Severe Acute Respiratory Syndrome CoV 2 pandemic><Severe Acute Respiratory Syndrome-associated coronavirus 2><Severe Acute Respiratory Syndrome-related coronavirus 2><Severe acute respiratory syndrome associated corona virus 2><Severe acute respiratory syndrome coronavirus 2><Severe acute respiratory syndrome coronavirus 2 epidemic><Severe acute respiratory syndrome coronavirus 2 pandemic><Severe acute respiratory syndrome coronavirus 2 therapeutics><Severe acute respiratory syndrome related corona virus 2><Severities><Shapes><Single cell seq><Sorting><Surface Proteins><Symptoms><System><T cell differentiation><T cell response><T-Cell Antigen Receptors><T-Cell Receptor><T-Cells><T-Lymphocyte><T4 Cells><T4 Lymphocytes><T8 Cells><T8 Lymphocytes><Techniques><Technology><Testing><Time><Vaccination><Vaccine Design><Vaccinee><Vaccines><Variant><Variation><Viral Diseases><Virus><Virus Diseases><Wuhan coronavirus><adaptive immune response><anamnestic reaction><anti-viral immunity><antigen-specific T cells><antiviral immunity><breakthrough infection><cDNA><cell biology><chronic COVID><chronic COVID-19><chronic novel coronavirus disease 2019><chronic symptom><cohort><combat><coronavirus disease 2019 consequence><coronavirus disease 2019 crisis><coronavirus disease 2019 disease severity><coronavirus disease 2019 effect><coronavirus disease 2019 epidemic><coronavirus disease 2019 global health crisis><coronavirus disease 2019 global pandemic><coronavirus disease 2019 health crisis><coronavirus disease 2019 impact><coronavirus disease 2019 infected patient><coronavirus disease 2019 pandemic><coronavirus disease 2019 patient><coronavirus disease 2019 positive patient><coronavirus disease 2019 public health crisis><coronavirus disease 2019 severity><coronavirus disease 2019 therapeutics><coronavirus disease 2019 virus><coronavirus disease crisis><coronavirus disease epidemic><coronavirus disease infected patient><coronavirus disease pandemic><coronavirus disease patient><coronavirus disease positive patient><coronavirus disease severity><coronavirus disease-19 global pandemic><coronavirus disease-19 impact><coronavirus disease-19 pandemic><coronavirus disease-19 patient><coronavirus disease-19 virus><coronavirus patient><customs><cytokine><daily living function><daily living functionality><debilitating symptom><design><designing><developmental><driving><epigenetically><functional ability><functional capacity><hCoV19><immunogen><improved><influenzavirus><innovate><innovation><innovative><insight><life-threatening COVID><life-threatening COVID-19><life-threatening SARS-CoV-2><life-threatening coronavirus disease><life-threatening coronavirus disease 2019><life-threatening severe acute respiratory syndrome coronavirus 2><long haul COVID><long haul COVID-19><long haul coronavirus disease><long haul coronavirus disease 2019><long-hauler COVID><long-hauler COVID-19><long-hauler coronavirus disease 2019><long-hauler syndrome><long-term COVID><long-term COVID-19><long-term coronavirus disease><long-term coronavirus disease 2019><longterm COVID><longterm COVID-19><longterm coronavirus disease><longterm coronavirus disease 2019><mRNA Expression><malignancy><mitochondrial><mortality><mtDNA><nCoV2><neoplasm/cancer><neutralizing antibody><novel><pandemic><pandemic disease><pathogenic virus><patient infected with COVID><patient infected with COVID-19><patient infected with SARS-CoV-2><patient infected with coronavirus disease><patient infected with coronavirus disease 2019><patient infected with severe acute respiratory syndrome coronavirus 2><patient with COVID><patient with COVID-19><patient with COVID19><patient with SARS-CoV-2><patient with coronavirus disease><patient with coronavirus disease 2019><patient with severe acute respiratory distress syndrome coronavirus 2><persistent COVID-19><persistent symptom><post COVID syndrome><post COVID-19 syndrome><post acute COVID syndrome><post acute COVID-19><post acute COVID-19 syndrome><post acute SARS-CoV-2><post acute coronavirus disease 2019><post acute coronavirus disease 2019 syndrome><post acute coronavirus disease syndrome><post acute severe acute respiratory syndrome coronavirus 2><post coronavirus disease 2019 syndrome><post coronavirus disease syndrome><post-acute phases of COVID-19><prevent><preventing><programs><prolonged COVID-19 symptoms><protein expression><response><secondary immune response><serious COVID><serious COVID-19><serious SARS-CoV-2><serious coronavirus disease><serious coronavirus disease 2019><serious severe acute respiratory syndrome coronavirus 2><severe COVID><severe COVID-19><severe COVID19><severe SARS-CoV-2><severe acute respiratory syndrome coronavirus 2 disease severity><severe acute respiratory syndrome coronavirus 2 global health crisis><severe acute respiratory syndrome coronavirus 2 global pandemic><severe acute respiratory syndrome coronavirus 2 infected patient><severe acute respiratory syndrome coronavirus 2 patient><severe acute respiratory syndrome coronavirus 2 positive patient><severe acute respiratory syndrome coronavirus 2 severity><severe coronavirus disease><severe coronavirus disease 19><severe coronavirus disease 2019><severe severe acute respiratory syndrome coronavirus 2><single cell next generation sequencing><single cell sequencing><therapeutics against COVID-19><therapeutics against SARS-CoV-2><therapeutics against SARS-coronavirus-2><therapeutics against Severe acute respiratory syndrome coronavirus 2><therapeutics against coronavirus disease 2019><therapeutics for novel coronavirus><thymus derived lymphocyte><vaccinated individual><vaccinated participant><vaccinated patient><vaccinated person><vaccinated subject><vaccine efficacy><viral infection><viral pathogen><virus infection><virus pathogen><virus-induced disease>